Adolescent and Young Adult Oncology Creates Some Buzz on the International Stage

re-posted from the ayavoice

  

Set against Auckland, New Zealand’s backdrop of black sand beaches and ocean for as far as the eyes can see, the 43rd Congress of the International Society of Pediatric Oncology (SIOP) provided experts from 93 countries an opportunity to come together. We’re proud to announce that two of our Adolescent and Young Adult (AYA) Oncology team members, Sue Lindemulder, MD and Amy Frohnmayer, were in attendance.

“The attention devoted to the AYA-specific concerns at this conference was an indication of the growing interest this field is cultivating. There is a lot of work to do, and it’s energizing to know that the mission of our program is shared by a larger network of providers, researchers, and advocates worldwide.” - Amy Frohnmayer, Research Assistant, AYA Oncology Program

There were multiple and varied sessions dedicated to AYA including five symposia, and the final keynote address. Ms. Frohnmayer presented on the fertility preservation decision-making process of adolescent and young adult women with cancer. Other topics ranged from long-term survivorship and care to the transition from pediatric to adult care, and AYA-specific disease physiology.
It wasn’t all serious business though. The exuberant atmosphere that AYA survivors bring to everything they do undoubtedly livened up the conference as many from Canteen New Zealand were in attendance as volunteers. The fun also included movie night and a screening of Wrong Way to Hope.
They AYA Program also had three posters presented at the conference.
AYA Fellowship
AYA Case Study
AYA Treatment & Survivorship Cohort

Adolescents and young adults with cancer have different needs from other patients. The Knight Cancer Institute is proud to offer Oregon’s only program designed exclusively for people ages 15-39. Our internationally-recognized, award-winning Adolescent and Young Adult (AYA) Oncology Program is dedicated to ensuring all AYAs with cancer have access to services tailored to their specific needs.

Pediatric Grand Rounds: COG Chair, Dr. Peter Adamson

Dr. Adamson will be giving the Robert C. Neerhout MD lecture on Thursday Nov 3 at 8am in the Doernbecher Children's Hospital Vey Auditorium (11th floor).  His lecture will be entitled, "Childhood Cancer Research: 21st Century Science, 20th Century Clinical Trials."
  
for a stream of the archived lecture, click here.  

Dr. Abraham presents at DIPG Conference (NIH)

Last week PCB senior scientist, Dr. Jinu Abraham, presented his invited talk entitled, "Rapid Preclinical development of targeted therapy combination for DIPG" at the DIPG Consensus Conference, which was held October 6-7^th at NIH's Bethesda campus.  A subject of the conference was determining the role of biopsy in the standard of care for this form of brainstem high grade glioma.  Noted to be equally important, however, is the search for a combination of targeted agents that makes this tumor a uniformly survivable condition.